2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow galidesivir: new trials by email Literature Review of galidesivir trials Research Report on galidesivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19 Galidesivir, Placebo - COVID-19, Yellow Fever | Phase 1 | Terminated | BioCryst Pharmaceuticals | 24 | 2020-04-09 | 2021-05-27 |
| A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 galidesivir, placebo - Marburg Virus Disease | Phase 1 | Completed | BioCryst Pharmaceuticals | 32 | 2018-12-10 | 2021-07-23 |
| A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430 BCX4430, Placebo - Filovirus Infections, Ebola Virus Infection | Phase 1 | Completed | BioCryst Pharmaceuticals | 94 | 2014-12-01 | 2016-07-07 |
COVID-19 (1) · Filoviridae Infections (1) · Hemorrhagic Fever, Ebola (1) · Marburg Virus Disease (1) · Yellow Fever (1)
Brazil (1) · United Kingdom (1) · United States (1)
Daniel Dickerson, MD, PhD (1) · Esper Kallas, MD, PhD (1) · Jo Collier, MBChB (1)
272201300017C-18-0-1 (2)